Comparing morning and evening aerobic exercise for heart recovery after a heart attack

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of aerobic exercise timing on cardiac remodeling and function in patients who have experienced an ST-segment Elevation Myocardial Infarction (STEMI). Participants will engage in either morning or evening aerobic exercise to determine which timing yields optimal cardiovascular benefits. The research aims to understand how the circadian rhythm influences the effectiveness of exercise in improving heart health post-STEMI. By analyzing the outcomes, the study seeks to provide evidence-based recommendations for exercise timing in cardiac rehabilitation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Between 18 and 75-years-old;
* Typical symptoms of acute myocardial infarction within 24 hours, with ST segment elevation of ≥1mm in two consecutive leads on electrocardiogram
* After receiving complete revascularization treatment
* Cardiac function grading I to II without any other serious complications
* Left ventricular ejection fraction \>30%
* Compliant with the guidelines of the American College of Cardiology/American Heart Association for participating in cardiac rehabilitation standards
* Signed written informed consent.

Exclusion Criteria:

* Patients with unstable angina
* severe symptomatic congestive heart failure detectable myocardial ischemia
* valvular disease requiring surgery
* severe ventricular arrhythmias
* severe concomitant life-threatening diseases such as cancer, and rheumatoid disease
* osteoarticular diseases that may affect the exercise process

Where it's running

• Renji Hospital
  Shanghai, China Recruiting

Study contacts

• Study coordinator: Jun PU, MD
• Email: pujun310@hotmail.com
• Phone: 13817577592

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adenosine given before primary PCI to reduce no-reflow in STEMI patients.

  See if giving intracoronary adenosine before primary PCI lowers the chance of slow flow/no-reflow in adults with STEMI.

  Recruiting at 2 sites Phase 4 National Institute of Cardiovascular Diseases, Pakistan · Karachi, Sindh and 1 other locations · NCT07536802

• Using cardiac MRI and AI to predict outcomes after STEMI

  This project will try to use routine cardiac MRI scans plus AI to see if imaging features can predict long-term outcomes in people who had a STEMI treated with primary PCI.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07072858

• Using beta-blockers for heart attack patients in intensive care

  This study is testing if the heart medication metoprolol can help heart attack patients in intensive care feel better and avoid worsening their condition.

  Recruiting Tel-Aviv Sourasky Medical Center · Tel Aviv · NCT06967194

• Using an aspiration catheter for treating heart attacks

  This study tests whether using a special catheter can help remove blood clots from the heart arteries during a heart attack to improve blood flow and patient recovery.

  Recruiting BrosMed Medical Co., Ltd · Shanghai, Shanghai Municipality · NCT06951724

• Using machine learning to improve early diagnosis of acute cardiovascular conditions

  This study is testing a new tool that uses advanced computer technology to help doctors quickly and accurately diagnose serious heart problems in patients who come to the emergency room with chest pain or trouble breathing.

  Recruiting University Hospital, Basel, Switzerland · Basel · NCT06927791

• Administering adrenaline in STEMI patients during PCI to prevent no reflow

  This study tests if giving adrenaline during heart procedures can help STEMI patients avoid complications with blood flow without causing heart rhythm problems.

  Recruiting Phase 3 Ain Shams University · Cairo · NCT06847568

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.